• SD 169 (Indole-5-carboxamide): Dual-Action p38 MAPK Inhibiti

  2026-05-25

  This article explores SD 169 (indole-5-carboxamide) as a next-generation, dual-action p38α/β MAPK inhibitor, blending mechanistic insights from recent kinase dephosphorylation studies with strategic guidance for translational researchers. We contextualize SD 169’s biological rationale, experimental validation, and translational impact, while distinguishing its advances from conventional inhibitors. Drawing on both peer-reviewed and workflow-focused literature, we provide actionable protocols and a forward-looking perspective for researchers tackling inflammation, neuroregeneration, and type 1 diabetes.

• Boc-D-FMK: Pan-Caspase Inhibitor for Apoptosis Research

  2026-05-24

  Boc-D-FMK is a cell-permeable, broad-spectrum pan-caspase inhibitor used in apoptosis research. It irreversibly inactivates caspases and is validated in both in vitro and in vivo inflammation models. Stringent handling protocols and context-aware application are essential for reproducibility.

• NF-κB/Apaf1/Caspase-9 Axis Drives Inflammation in Septic AKI

  2026-05-23

  This study uncovers the sequential activation of the NF-κB/Apaf1/caspase-9 signaling axis as a key driver of tubular inflammation and apoptosis in septic acute kidney injury. By elucidating the mechanistic suppression of autophagy and demonstrating the therapeutic potential of targeting this pathway, the research advances our understanding of septic AKI pathophysiology and points to new intervention strategies.

• 17-AAG (Tanespimycin): Precision HSP90 Inhibition in Oncolog

  2026-05-22

  17-AAG (Tanespimycin) is a synthetic HSP90 inhibitor with low-nanomolar potency in cancer models. It induces apoptosis by destabilizing oncogenic client proteins, disrupts MAPK signaling, and shows efficacy across multiple tumor types. The compound’s selectivity and solubility profile make it a preferred tool for HSP90 chaperone inhibition in cancer research.

• Coronavirus Macrodomain Counters PARP-Mediated Antiviral Res

  2026-05-22

  Grunewald et al. (2019) reveal that the coronavirus macrodomain is essential for evading host poly (ADP-ribose) polymerase (PARP)-mediated suppression of viral replication and for restricting interferon (IFN) expression. These findings clarify the interplay between viral macrodomains and host innate immunity, highlighting new avenues for antiviral research.

• Magneto-Piezoelectric Scaffolds Target JAK2-STAT3 in Bone Re

  2026-05-21

  Wu et al. report a multifunctional scaffold integrating magneto-piezoelectric nanoparticles, which disrupt bacterial biofilms and selectively activate oxidative phosphorylation in Icam1+ macrophages for infectious bone defect regeneration. By targeting the JAK2-STAT3 pathway, this approach offers a dual therapeutic strategy—controlling infection and promoting bone healing—with implications for advanced regenerative biomaterials.

• Toremifene: Precision Tool for Selective Estrogen-Receptor M

  2026-05-21

  Toremifene empowers researchers to dissect estrogen receptor signaling and calcium-driven metastatic pathways in hormone-responsive prostate cancer models. This guide delivers actionable workflows, troubleshooting insights, and translational strategies to leverage Toremifene’s potent, quantifiable activity in advanced experimental settings.

• TSPAN18 Protects STIM1 to Drive Bone Metastasis in Prostate

  2026-05-20

  Zhou et al. reveal that TSPAN18 promotes bone metastasis in prostate cancer by inhibiting TRIM32-mediated ubiquitination of STIM1, stabilizing STIM1 protein and activating calcium signaling. This mechanistic insight highlights TSPAN18 as a potential therapeutic target and provides new context for designing advanced hormone-responsive cancer research workflows.

• TPPU and Soluble Epoxide Hydrolase Inhibition: Redefining Li

  2026-05-20

  Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, advances research on lipid signaling, bone metabolism, and chronic inflammation. This article uniquely dissects new mechanistic insights and practical assay implications, setting it apart from prior reviews.

• SB 203580: Precision Targeting of p38 MAPK in Regenerative R

  2026-05-19

  Explore the multifaceted applications of SB203580, a selective p38 MAPK inhibitor, in regenerative medicine and advanced cell signaling studies. This article delivers a deep dive into its molecular action, translational relevance, and protocol nuances that distinguish its use in next-generation research.

• 12-O-tetradecanoyl phorbol-13-acetate (TPA): Precision Contr

  2026-05-19

  Explore how 12-O-tetradecanoyl phorbol-13-acetate (TPA) enables precise, tunable ERK/MAPK pathway activation for advanced disease modeling and signal transduction assay design. This article delivers a deeper mechanistic perspective, focusing on actionable insights for researchers.

• Distinct Apoptotic Pathways in BMECs Induced by C. krusei Ph

  2026-05-18

  This study demonstrates that Candida krusei induces apoptosis in bovine mammary epithelial cells (BMECs) via distinct mechanisms, with the yeast phase activating a mitochondrial pathway and the hypha phase triggering a death ligand/receptor pathway. The findings deepen our understanding of mycotic mastitis pathogenesis and point to specific MAPK signaling components as potential therapeutic targets.

• Universal Method for Dual-Loaded Liposome Encapsulation Effi

  2026-05-18

  This study introduces a robust nanoparticle exclusion chromatography (nPEC) method for accurately determining the encapsulation efficiency of dual-loaded liposomes containing both hydrophilic and lipophilic drugs. The findings advance drug delivery research by enabling precise, reproducible assessment across diverse compound pairs, supporting translational applications in combination therapy.

• PPM-18 for Precision NF-κB Inhibition in Sepsis Research

  2026-05-17

  PPM-18, a potent NF-κB pathway inhibitor, empowers researchers to achieve reproducible iNOS modulation in inflammation and sepsis models. Applied insights, protocol guidance, and troubleshooting tips maximize its impact for translational studies.

• Cannabidiol’s Role in Modulating Orofacial Inflammatory Pain

  2026-05-16

  This study demonstrates that cannabidiol (CBD) robustly attenuates both sensory and affective dimensions of orofacial inflammatory pain in mouse models, acting through peripheral and central endocannabinoid and serotonergic pathways. These findings highlight CBD’s translational potential for integrated management of pain and mood disturbances, and inform future investigations into endocannabinoid signaling modulation.

8612 records 13/575 page Previous Next First page 上5页 1112131415 下5页 Last page